Shannon Thyme Klinger - 12 Feb 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Legal Officer
Signature
/s/ James Dillon, as Attorny-in-Fact
Issuer symbol
MRNA
Transactions as of
12 Feb 2025
Net transactions value
-$33,033
Form type
4
Filing time
14 Feb 2025, 16:15:47 UTC
Previous filing
10 Dec 2024
Next filing
28 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Award $0 +2,047 +10% $0.000000 22,493 12 Feb 2025 Direct F1
transaction MRNA Common Stock Tax liability $33,033 -1,068 -4.7% $30.93 21,425 12 Feb 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on March 1, 2022 (the "2022 PSUs").
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2022 PSUs.